Vigabatrin aggravates absences and absence status.
Panayiotopoulos
C P
CP
Department of Clinical Neurophysiology and Epilepsies, St. Thomas' Hospital, London, UK.
Agathonikou
A
A
Sharoqi
I A
IA
Parker
A P
AP
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D004569:Electroencephalography; D004832:Epilepsy, Absence / Q000139:chemically induced* / Q000503:physiopathology; D004829:Epilepsy, Generalized / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin